Bastiaan G. Wortman
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Cost-utility-analysis of molecular-integrated-profile for women with (high)intermediate risk endometrial cancer - PORTEC-4a an international, randomised, phase 3 trial.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: December 16, 2025
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial.
Journal: The Lancet. Oncology
Published: June 11, 2025
Thromboprophylaxis in patients with locally advanced cervical cancer treated with chemoradiation and brachytherapy.
Journal: Gynecologic oncology
Published: September 17, 2024
Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials.
Journal: The Lancet. Oncology
Published: November 27, 2023
Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 24, 2023
Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy.
Journal: International journal of radiation oncology, biology, physics
Published: July 14, 2021
PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: August 17, 2020
Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: August 06, 2020
Selecting Adjuvant Treatment for Endometrial Carcinoma Using Molecular Risk Factors.
Journal: Current oncology reports
Published: August 02, 2019
Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: Evaluation of the pilot phase of the PORTEC-4a trial.
Journal: Gynecologic oncology
Published: May 01, 2018
Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy.
Journal: British journal of cancer
Published: April 12, 2018
Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 01, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026